About Brio Device
Brio Device is a company based in Doylestown (United States) founded in 2010. Brio Device has raised $1.94 million across 7 funding rounds from investors including HHS, Innovation Fund America and Quantum Medical Concepts. Brio Device operates in a competitive market with competitors including Belluscura, hemovent, ALung, Lungpacer and OneBreath, among others.
- Headquarter Doylestown, United States
- SectorsHealthcare
- Website briodevice.com
- Social LinkedIn Facebook
- Legal Name Brio Device, Llc
- Total Equity Funding$1.94M (USD)
in 7 rounds
- Latest Funding Round$500K (USD), Seed
Oct 2019
- InvestorsHHS
& 2 more
Funding Insights of Brio Device
Brio Device has successfully raised a total of $1.94M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.94M
- Total Rounds 7
- Last Round Seed — $500,000
- First Round $1,200
(Feb 2011)
- Investors Count 3
All 7 funding rounds of Brio Device with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $500,000 | Seed | – | – | – |
| Dec 2017 | $1.29M | Seed | – | – | – |
| Jan 2017 | $100,000 | Grant | – | – | |
| Sep 2016 | $1.4M | Grant | – | – | |
| Nov 2015 | $150,000 | Seed | – | – | |
| Sep 2013 | $244,710 | Grant | – | – | |
| Feb 2011 | $1,200 | Grant | – | – | – |
3 investors in total: 3 institutional.
Investors in Brio Device
Brio Device has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Innovation Fund America and Quantum Medical Concepts.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & Life Science focused seed stage VC firm investing in the US | – | innovationfundamerica.org | Elyria, United States | |
- | – | quantummedicalconcepts.com | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Brio Device
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Brio Device
3 dated milestones of Brio Device across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Brio Device is founded.
- Funding First funding round of $1K.
- Funding Latest funding round, Seed, of $500K.
Competitors of Brio Device
Brio Device operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Belluscura, hemovent, ALung, Lungpacer and OneBreath, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| belluscura.com | 2015 | Dallas, United States | $6.38M | 21 | Provider of medical devices for laparoscopic procedures | |
| hemovent.com | 2013 | Aachen, Germany | $16.7M | 23 | Equipment for extracorporeal life support and CO2 removal is developed. | |
| alung.com | 1997 | Pittsburgh, United States | $132.56M | 27 | Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation. | |
| lungpacer.com | 2009 | Vancouver, Canada | $121.38M | 62 | Neurostimulation-based pacer for diaphragm strength is developed. | |
| onebreathventilators.com | 2013 | Bengaluru, India | $3.45M | 26 | Portable mechanical ventilators for intensive care patients are developed. | |
| securisyn.com | 2011 | Denver, United States | $16.79M | – | Endotracheal tube stabilization systems for ventilated patients are developed. | |
| breethe.com | 2014 | Montreal, Canada | – | – | Meditation programs are delivered through a mobile app by Breethe. |
Detailed competitors of Brio Device
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Brio Device
10 companies that operate in the same segment as Brio Device (Pulmonology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Cancer detection diagnostics assays are developed and offered. | 2005 | Boulder, Colorado, United States | USD 200.16 M | USD 88.5 M | 273 | |
Therapeutic devices for nasal breathing improvement are developed. | 2011 | Sunnyvale, California, United States | USD 176.4 M | – | 66 | |
Non-invasive breath-based diagnostics for cancer and infectious diseases are developed. | 2004 | Cambridge, Cambridgeshire, United Kingdom | USD 166.55 M | – | 202 | |
Protein biologics are developed for treating rare diseases. | 2005 | San Diego, California, United States | USD 171.52 M | USD 190 K | 59 | |
Therapeutics for rare respiratory diseases are developed by Savara Pharma. | 2008 | Austin, Texas, United States | USD 67.82 M | – | 59 | |
Developer of smart devices for treating pulmonary diseases | 1998 | Redwood City, California, United States | USD 280.91 M | USD 90.5 M | 291 | |
A norovirus vaccine is developed for infection prevention. | 2021 | Boston, Massachusetts, United States | USD 135 M | – | 14 | |
Oral small molecule drugs for chronic diseases are developed. | 2017 | San Francisco, California, United States | USD 233 M | – | 163 | |
Precision medicines for lung-related diseases are developed. | 2015 | Menlo Park, California, United States | USD 371 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Brio Device
Brio Device was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Brio Device is headquartered in Doylestown, United States. It is registered at Doylestown, Pennsylvania, United States.
Brio Device is a funded company, having raised a total of $1.94M across 7 funding rounds to date. The company's 1st funding round was a Grant of $1.2K, raised on Feb 2011.
Brio Device was founded in 2010 and is located in Doylestown, United States. Operations focus on the medical devices sector, where instruments for emergency medical services and first responders are developed and commercialized. Anatomic image recognition technology and machine learning are incorporated to support procedures such as endotracheal intubation. The initial product addresses intubation efficacy and safety, targeting scenarios involving less-experienced practitioners in emergencies, where failure rates can reach 20-40.
Brio Device's top competitors include Belluscura, Lungpacer and hemovent.
Brio Device has 3 investors. Key investors include HHS, Innovation Fund America, and Quantum Medical Concepts.
Brio Device operates through Brio Device, Llc.